Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Indra Sarabia

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Viruses|December 5, 2019
HIV-1 Latency and Latency Reversal: Does Subtype Matter?Indra Sarabia, Alberto Bosque
Journal of Virology|January 14, 2021
The Intact Non-Inducible Latent HIV-1 Reservoir is Established In an <i>In Vitro</i> Primary T<sub>CM</sub> Cell Model of LatencyIndra Sarabia, Szu-Han Huang, Adam R Ward, et al.
Nano Research|June 3, 2021
PLGA nanodepots co-encapsulating prostratin and anti-CD25 enhance primary natural killer cell antiviral and antitumor functionElizabeth E Sweeney, Preethi B Balakrishnan, Allison B Powell, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2020
Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 Latency-Reversing AgentsEric S Sorensen, Amanda B Macedo, Rachel S Resop, et al.
Plos Pathogens|November 30, 2020
Human splice factors contribute to latent HIV infection in primary cell models and blood CD4+ T cells from ART-treated individualsSara Moron-Lopez, Sushama Telwatte, Indra Sarabia, et al.
Frontiers in Immunology|July 1, 2021
Activation of the Anti-Oxidative Stress Response Reactivates Latent HIV-1 Through the Mitochondrial Antiviral Signaling Protein Isoform MiniMAVSIndra Sarabia, Camille L Novis, Amanda B Macedo, et al.
Frontiers in Immunology|March 27, 2025
Guselkumab binding to CD64<sup>+</sup> IL-23-producing myeloid cells enhances potency for neutralizing IL-23 signalingKacey L Sachen, Deepa Hammaker, Indra Sarabia, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Viruses|December 5, 2019
HIV-1 Latency and Latency Reversal: Does Subtype Matter?Indra Sarabia, Alberto Bosque
Journal of Virology|January 14, 2021
The Intact Non-Inducible Latent HIV-1 Reservoir is Established In an <i>In Vitro</i> Primary T<sub>CM</sub> Cell Model of LatencyIndra Sarabia, Szu-Han Huang, Adam R Ward, et al.
Nano Research|June 3, 2021
PLGA nanodepots co-encapsulating prostratin and anti-CD25 enhance primary natural killer cell antiviral and antitumor functionElizabeth E Sweeney, Preethi B Balakrishnan, Allison B Powell, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2020
Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 Latency-Reversing AgentsEric S Sorensen, Amanda B Macedo, Rachel S Resop, et al.
Plos Pathogens|November 30, 2020
Human splice factors contribute to latent HIV infection in primary cell models and blood CD4+ T cells from ART-treated individualsSara Moron-Lopez, Sushama Telwatte, Indra Sarabia, et al.
Frontiers in Immunology|July 1, 2021
Activation of the Anti-Oxidative Stress Response Reactivates Latent HIV-1 Through the Mitochondrial Antiviral Signaling Protein Isoform MiniMAVSIndra Sarabia, Camille L Novis, Amanda B Macedo, et al.
Frontiers in Immunology|March 27, 2025
Guselkumab binding to CD64<sup>+</sup> IL-23-producing myeloid cells enhances potency for neutralizing IL-23 signalingKacey L Sachen, Deepa Hammaker, Indra Sarabia, et al.
Pageof 1